Table 5.
Factors associated with elevated TG by gender.
| Q1 | Q2 | Q3 | Q4 | |
|---|---|---|---|---|
| Men | ||||
| GGT (U/L) | ≤20 | 21–29 | 30–43 | ≥44 |
| Cases/subjects at risk | 212/1,178 | 272/1,213 | 328/1,167 | 402/1,206 |
| OR (95% CI: lower–upper) | 1.00 | 2.03 (1.63–2.55) | 3.10 (2.47–3.89) | 4.79 (3.78–6.08) |
| ALT (U/L) | ≤19 | 20–27 | 28–38 | ≥39 |
| Cases/subjects at risk | 160/1,191 | 283/1,201 | 297/1,188 | 444/1,184 |
| OR (95% CI: lower–upper) | 1.00 | 1.38 (1.12–1.71) | 1.56 (1.26–1.94) | 1.74 (1.36–2.23) |
| AST (U/L) | ≤24 | 25–30 | 31–36 | ≥37 |
| Cases/subjects at risk | 272/1,214 | 264/1,294 | 298/1,145 | 380/1,111 |
| OR (95% CI: lower–upper) | 1.00 | 1.21 (0.99–1.47) | 1.44 (1.17–1.77) | 1.75 (1.39–2.20) |
| ALP (U/L) | ≤52 | 53–61 | 62–71 | ≥72 |
| Cases/subjects at risk | 241/1,288 | 289/1,106 | 322/1,202 | 362/1,168 |
| OR (95% CI: lower–upper) | 1.00 | 1.29 (1.06–1.56) | 1.31 (1.09–1.52) | 1.40 (1.16–1.69) |
| Women | ||||
| GGT (U/L) | ≤13 | 14–17 | 18–22 | ≥23 |
| Cases/subjects at risk | 302/1,843 | 299/1,386 | 334/1,151 | 553/1,409 |
| OR (95% CI: lower–upper) | 1.00 | 1.73 (1.22–2.47) | 3.68 (2.65–5.11) | 5.15 (3.70–7.16) |
| ALT (U/L) | ≤13 | 14–18 | 19–23 | ≥24 |
| Cases/subjects at risk | 280/1,480 | 358/1,624 | 334/1,248 | 516/1,437 |
| OR (95% CI: lower–upper) | 1.00 | 1.39 (0.99–1.94) | 1.62 (1.15–2.27) | 1.81 (1.27–2.57) |
| AST (U/L) | ≤22 | 23–26 | 27–31 | ≥32 |
| Cases/subjects at risk | 307/1,451 | 350/1,494 | 361/1,434 | 470/1,410 |
| OR (95% CI: lower–upper) | 1.00 | 1.24 (0.91–1.69) | 1.22 (0.90–1.65) | 1.68 (1.24–2.30) |
| ALP (U/L) | ≤42 | 43–51 | 52–63 | ≥64 |
| Cases/subjects at risk | 271/1,556 | 331/1,352 | 428/1,519 | 458/1,362 |
| OR (95% CI: lower–upper) | 1.00 | 1.45 (1.06–1.99) | 1.72 (1.29–2.31) | 2.06 (1.53–2.78) |
Abbreviations: TG = triglyceride; GGT = gamma-glutamyl transferase; ALT = alanine aminotransferase; AST = aspartate aminotransferase; ALP = alkaline phosphatase; OR = odds ratio; CI = confidence interval.